Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
Article has an altmetric score of 2

See more details

Posted by 4 X users
38 readers on Mendeley
  • Article usage
  • Citations to this article (0)

Advertisement

Corrigendum Free access | 10.1172/JCI154834

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine

Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, Rony Chen, Rachel Gomez-Tolub, Eran Hadar, Rinat Gabbay-Benziv, Yuval Jaffe Moshkovich, Tal Biron-Shental, Gil Shechter-Maor, Sivan Farladansky-Gershnabel, Hen Yitzhak Sela, Hedi Benyamini-Raischer, Nitzan D. Sela, Debra Goldman-Wohl, Ziv Shulman, Ariel Many, Haim Barr, Simcha Yagel, Michal Neeman, and Michal Kovo

Find articles by Beharier, O. in: JCI | PubMed | Google Scholar

Find articles by Plitman Mayo, R. in: JCI | PubMed | Google Scholar

Find articles by Raz, T. in: JCI | PubMed | Google Scholar

Find articles by Nahum Sacks, K. in: JCI | PubMed | Google Scholar

Find articles by Schreiber, L. in: JCI | PubMed | Google Scholar

Find articles by Suissa-Cohen, Y. in: JCI | PubMed | Google Scholar

Find articles by Chen, R. in: JCI | PubMed | Google Scholar

Find articles by Gomez-Tolub, R. in: JCI | PubMed | Google Scholar

Find articles by Hadar, E. in: JCI | PubMed | Google Scholar

Find articles by Gabbay-Benziv, R. in: JCI | PubMed | Google Scholar

Find articles by Moshkovich, Y. in: JCI | PubMed | Google Scholar

Find articles by Biron-Shental, T. in: JCI | PubMed | Google Scholar

Find articles by Shechter-Maor, G. in: JCI | PubMed | Google Scholar

Find articles by Farladansky-Gershnabel, S. in: JCI | PubMed | Google Scholar

Find articles by Yitzhak Sela, H. in: JCI | PubMed | Google Scholar

Find articles by Benyamini-Raischer, H. in: JCI | PubMed | Google Scholar

Find articles by Sela, N. in: JCI | PubMed | Google Scholar

Find articles by Goldman-Wohl, D. in: JCI | PubMed | Google Scholar

Find articles by Shulman, Z. in: JCI | PubMed | Google Scholar

Find articles by Many, A. in: JCI | PubMed | Google Scholar

Find articles by Barr, H. in: JCI | PubMed | Google Scholar

Find articles by Yagel, S. in: JCI | PubMed | Google Scholar

Find articles by Neeman, M. in: JCI | PubMed | Google Scholar

Find articles by Kovo, M. in: JCI | PubMed | Google Scholar

Published October 1, 2021 - More info

Published in Volume 131, Issue 19 on October 1, 2021
J Clin Invest. 2021;131(19):e154834. https://doi.org/10.1172/JCI154834.
© 2021 American Society for Clinical Investigation
Published October 1, 2021 - Version history
View PDF

Related article:

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Ofer Beharier, … , Michal Neeman, Michal Kovo
Ofer Beharier, … , Michal Neeman, Michal Kovo
Clinical Research and Public Health Reproductive biology Article has an altmetric score of 329

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine

  • Text
  • PDF
Abstract

BACKGROUND The significant risks posed to mothers and fetuses by COVID-19 in pregnancy have sparked a worldwide debate surrounding the pros and cons of antenatal SARS-CoV-2 inoculation, as we lack sufficient evidence regarding vaccine effectiveness in pregnant women and their offspring. We aimed to provide substantial evidence for the effect of the BNT162b2 mRNA vaccine versus native infection on maternal humoral, as well as transplacentally acquired fetal immune response, potentially providing newborn protection.METHODS A multicenter study where parturients presenting for delivery were recruited at 8 medical centers across Israel and assigned to 3 study groups: vaccinated (n = 86); PCR-confirmed SARS-CoV-2 infected during pregnancy (n = 65), and unvaccinated noninfected controls (n = 62). Maternal and fetal blood samples were collected from parturients prior to delivery and from the umbilical cord following delivery, respectively. Sera IgG and IgM titers were measured using the Milliplex MAP SARS-CoV-2 Antigen Panel (for S1, S2, RBD, and N).RESULTS The BNT162b2 mRNA vaccine elicits strong maternal humoral IgG response (anti-S and RBD) that crosses the placenta barrier and approaches maternal titers in the fetus within 15 days following the first dose. Maternal to neonatal anti-COVID-19 antibodies ratio did not differ when comparing sensitization (vaccine vs. infection). IgG transfer ratio at birth was significantly lower for third-trimester as compared with second trimester infection. Lastly, fetal IgM response was detected in 5 neonates, all in the infected group.CONCLUSION Antenatal BNT162b2 mRNA vaccination induces a robust maternal humoral response that effectively transfers to the fetus, supporting the role of vaccination during pregnancy.FUNDING Israel Science Foundation and the Weizmann Institute Fondazione Henry Krenter.

Authors

Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, Rony Chen, Rachel Gomez-Tolub, Eran Hadar, Rinat Gabbay-Benziv, Yuval Jaffe Moshkovich, Tal Biron-Shental, Gil Shechter-Maor, Sivan Farladansky-Gershnabel, Hen Yitzhak Sela, Hedi Benyamini-Raischer, Nitzan D. Sela, Debra Goldman-Wohl, Ziv Shulman, Ariel Many, Haim Barr, Simcha Yagel, Michal Neeman, Michal Kovo

×

Original citation: J Clin Invest. 2021;131(13):e150319. https://doi.org/10.1172/JCI150319

Citation for this corrigendum: J Clin Invest. 2021;131(19):e154834. https://doi.org/10.1172/JCI154834

For clarity, the authors are updating Figure 1, the flow chart for this study, to better illustrate the excluded samples and criteria for exclusion. The HTML and PDF versions of the figure and its legend have been updated.

Patient selection flow chart.Figure 1

Patient selection flow chart. Patients were recruited from 8 medical centers in Israel and were all SARS-CoV-2 RT-PCR negative at delivery. The original study groups included all the paired samples from the vaccinated (n = 92) and SARS-CoV-2 (n = 74) groups together with the original matched control group (n = 66). Samples were thereafter excluded for technical testing problems, leading to a total of n = 62, n = 65, and n = 86 analyzed samples for the control, SARS-CoV-2, and vaccinated groups, respectively. Seropositivity for nucleocapsid (N) was set at the level of the top 90% of the PCR-positive recovered group and verified by positivity for S1, S2, and RBD (see Supplemental Figures 1 and 2). The same threshold was used to reveal seropositive cases in the vaccinated and the control groups.

Footnotes

See the related article at Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.

Version history
  • Version 1 (October 1, 2021): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 2
  • Article usage
  • Citations to this article (0)

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 4 X users
38 readers on Mendeley
See more details
Picked up by 18 news outlets
Blogged by 2
Referenced in 1 policy sources
Posted by 263 X users
On 3 Facebook pages
Highlighted by 1 platforms
295 readers on Mendeley
See more details